Health Economics

Hexvix® is cost effective in the treatment and management of NMIBC^8,22

Hexvix^® and single shot mitomycin (MMC) led to a reduction in the number of TURBTs and patients requiring in-hospital admission compared to WLC²⁷

The use of Hexvix^® to assist primary TURBT is more expensive than WLC alone

Hexvix® combined with single shot mitomycin (MMC) led to a reduction in the number of TURBTs and patients requiring in-hospital admission compared to WLC²⁷

Hexvix® use led to reduced healthcare costs⁸